Wordt geladen...
Activity of second-generation ALK inhibitors against crizotinib-resistant mutants in an NPM-ALK model compared to EML4-ALK
Anaplastic lymphoma kinase (ALK) is a tyrosine kinase receptor involved in both solid and hematological tumors. About 80% of ALK-positive anaplastic large-cell lymphoma (ALCL) cases are characterized by the t(2;5)(p23;q35) translocation, encoding for the aberrant fusion protein nucleophosmin (NPM)-A...
Bewaard in:
| Gepubliceerd in: | Cancer Med |
|---|---|
| Hoofdauteurs: | , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
John Wiley & Sons, Ltd
2015
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4529334/ https://ncbi.nlm.nih.gov/pubmed/25727400 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.413 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|